CUMBERLAND PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2023 · Filed Mar 13, 2024
Contents
Cover page
Show cover page
DEF 14A 1 a2023proxystatement.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrantþ
Filed by a Party other than the Registranto
Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
þ Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to §240.14a-12
Payment of Filing Fee (Check the appropriate box):
| þ | No fee required. |
|---|---|
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Title of each class of securities to which transaction applies: |
| (2) | Aggregate number of securities to which transaction applies: |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
| (4) | Proposed maximum aggregate value of transaction: |
| (5) | Total fee paid: |
| o | Fee paid previously with preliminary materials |
|---|---|
| o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| (1) | Amount previously paid: |
| (2) | Form, Schedule or Registration Statement No.: |
| (3) | Filing Party: |
| (4) | Date Filed: |
TABLE OF CONTENTS
| Page Number | |
|---|---|
| NOTICE OF ANNUAL MEETING OF SHAREHOLDERS | 1 |
| PROXY STATEMENT FOR ANNUAL MEETING OF SHAREHOLDERS TO BE HELD APRIL 23, 2024 | 4 |
| PROPOSAL I | 7 |
| PROPOSAL II | 11 |
| AUDIT COMMITTEE REPORT | 12 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 16 |
| DELINQUENT SECTION 16(a) REPORTS | 17 |
| COMPENSATION DISCUSSION AND ANALYSIS | 18 |
| EXECUTIVE COMPENSATION AND RELATED INFORMATION | 26 |
| GRANTS OF PLAN-BASED AWARDS | 29 |
| CORPORATE GOVERNANCE | 37 |
| SHAREHOLDER PROPOSALS | 41 |
| OTHER MATTERS | 41 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.